Influenza, RSV and Respiratory Virus Vaccines

This session will examine vaccine research and immunization strategies targeting influenza, respiratory syncytial virus (RSV), COVID-19, and other respiratory pathogens. Discussions will cover vaccine development, antigenic variation, immune responses, effectiveness, seasonal vaccination, booster strategies, and vaccination of vulnerable populations. Researchers may present findings from clinical trials, surveillance studies, and real-world vaccine programmes. The session will also consider challenges associated with rapidly changing respiratory viruses and the need for adaptable vaccine technologies. Speakers will discuss strategies for improving vaccination coverage among children, older adults, healthcare workers, and individuals at increased risk of severe disease. The session provides an opportunity for virologists, immunologists, clinicians, epidemiologists, vaccine developers, and public-health professionals to exchange knowledge on respiratory virus prevention.

    Related Conference of Influenza, RSV and Respiratory Virus Vaccines

    September 28-29, 2026

    8th World Congress on Vaccine and Immunology

    Toronto, Canada
    November 16-17, 2026

    7th International Conference on Vaccine Research

    Tokyo, Japan

    Influenza, RSV and Respiratory Virus Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in